Envestnet Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$21.2 - $31.03 $11,596 - $16,973	547 Added 6.48%	8,989 $275,000
Q3 2023 Nov 13, 2023	SELL	$26.2 - $36.08 $53,369 - $73,494	-2,037 Reduced 19.44%	8,442 $226,000
Q2 2023 Aug 04, 2023	BUY	$25.16 - $41.38 $263,651 - $433,621	10,479 New	10,479 $373,000
Q4 2022 Feb 07, 2023	SELL	$28.0 - $40.56 $59,500 - $86,190	-2,125 Reduced 5.98%	33,383 $1.35 Million
Q3 2022 Nov 10, 2022	SELL	$29.63 - $48.31 $25,718 - $41,933	-868 Reduced 2.39%	35,508 $1.17 Million
Q2 2022 Aug 03, 2022	SELL	$27.79 - $50.61 $17,257 - $31,428	-621 Reduced 1.68%	36,376 $1.28 Million
Q1 2022 May 04, 2022	SELL	$39.62 - $69.97 $75,317 - $133,012	-1,901 Reduced 4.89%	36,997 $1.7 Million
Q4 2021 Feb 04, 2022	SELL	$58.09 - $82.51 $287,080 - $407,764	-4,942 Reduced 11.27%	38,898 $2.58 Million
Q3 2021 Oct 07, 2021	BUY	$58.38 - $84.96 $187,574 - $272,976	3,213 Added 7.91%	43,840 $2.74 Million
Q2 2021 Aug 04, 2021	BUY	$62.15 - $90.32 $101,428 - $147,402	1,632 Added 4.19%	40,627 $3.37 Million
Q1 2021 May 04, 2021	BUY	$61.35 - $90.47 $336,198 - $495,775	5,480 Added 16.35%	38,995 $2.59 Million
Q4 2020 Feb 02, 2021	SELL	$43.82 - $85.37 $8,720 - $16,988	-199 Reduced 0.59%	33,515 $2.57 Million
Q3 2020 Oct 09, 2020	SELL	$33.21 - $51.27 $99,762 - $154,015	-3,004 Reduced 8.18%	33,714 $1.45 Million
Q2 2020 Jul 08, 2020	SELL	$26.12 - $43.27 $32,806 - $54,347	-1,256 Reduced 3.31%	36,718 $1.59 Million
Q1 2020 Apr 23, 2020	SELL	$20.56 - $63.12 $188,494 - $578,684	-9,168 Reduced 19.45%	37,974 $1.09 Million
Q4 2019 Feb 11, 2020	BUY	$28.14 - $73.01 $375,443 - $974,099	13,342 Added 39.47%	47,142 $2.99 Million
Q3 2019 Oct 17, 2019	BUY	$26.26 - $34.86 $46,033 - $61,109	1,753 Added 5.47%	33,800 $952,000
Q2 2019 Aug 02, 2019	BUY	$17.43 - $28.82 $17,360 - $28,704	996 Added 3.21%	32,047 $849,000
Q1 2019 May 10, 2019	SELL	$12.05 - $20.18 $11,845 - $19,836	-983 Reduced 3.07%	31,051 $570,000
Q4 2018 Feb 13, 2019	BUY	$10.74 - $19.7 $344,045 - $631,069	32,034 New	32,034 $398,000

Others Institutions Holding ARWR

# of Institutions

295

Shares Held

91.1M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account